Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 162(9): 5112-8, 1999 May 01.
Article in English | MEDLINE | ID: mdl-10227981

ABSTRACT

Delivery of IgA to the mucosal surface occurs via transcytosis of polymeric IgA (pIgA) across the epithelium, a process mediated by the pIgR. Several factors increase pIgR expression in human epithelial cells, including IL-4 and IFN-gamma. Using an RNase protection assay, we found that IL-4 and IFN-gamma increase steady state levels of pIgR mRNA in both human intestinal (HT29) and airway (Calu-3) epithelial cells. Time course studies in HT29 clone 19A cells showed that with each cytokine alone and with both together: 1) there was a significant lag before mRNA levels increased; 2) maximal levels were not reached until 48-72 h after the addition of cytokines; 3) mRNA levels remained elevated in the continued presence of cytokines; and 4) addition of actinomycin D or removal of cytokines led to decreases in mRNA levels with a half-life of approximately 20-28 h. Cytokine-dependent increases in steady state levels of pIgR mRNA were inhibited by cycloheximide and by protein tyrosine kinase inhibitors but not by inhibitors of protein kinase C or cAMP-dependent protein kinase A. Both IFN-gamma and IL-4 increased expression of the inducible transcription factor IFN regulatory factor-1 (IRF-1), but levels of IRF-1 only weakly correlated with levels of pIgR mRNA, suggesting that additional transcription factors are required. These studies provide additional insights into the mechanisms by which cytokines regulate expression of the pIgR, a central player in mucosal immunity.


Subject(s)
Interferon-gamma/physiology , Interleukin-4/physiology , Intestinal Mucosa/metabolism , Lung/metabolism , RNA, Messenger/metabolism , Receptors, Polymeric Immunoglobulin/genetics , Receptors, Polymeric Immunoglobulin/metabolism , Cycloheximide/pharmacology , Cytokines/physiology , DNA-Binding Proteins/biosynthesis , Drug Synergism , Enzyme Inhibitors/pharmacology , Epithelial Cells/immunology , Epithelial Cells/metabolism , HT29 Cells/metabolism , Humans , Interferon Regulatory Factor-1 , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Lung/cytology , Lung/drug effects , Phosphoproteins/biosynthesis , Protein-Tyrosine Kinases/antagonists & inhibitors , Proto-Oncogene Proteins c-jun/biosynthesis , RNA, Messenger/drug effects , Time Factors , Transcription Factors/biosynthesis , Tumor Cells, Cultured
2.
Infect Immun ; 66(12): 5777-84, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9826354

ABSTRACT

Pseudomonas aeruginosa, an opportunistic human pathogen, causes acute pneumonia in patients with hospital-acquired infections and is commonly associated with chronic lung disease in individuals with cystic fibrosis (CF). Evidence suggests that the pathophysiological effects of P. aeruginosa are mediated in part by virulence factors secreted by the bacterium. Among these factors is pyocyanin, a redox active compound that increases intracellular oxidant stress. We find that pyocyanin increases release of interleukin-8 (IL-8) by both normal and CF airway epithelial cell lines and by primary airway epithelial cells. Moreover, pyocyanin synergizes with the inflammatory cytokines tumor necrosis factor alpha and IL-1alpha. RNase protection assays indicate that increased IL-8 release is accompanied by increased levels of IL-8 mRNA. The antioxidant n-acetyl cysteine, general inhibitors of protein tyrosine kinases, and specific inhibitors of mitogen-activated protein kinases diminish pyocyanin-dependent increases in IL-8 release. Conversely, inhibitors of protein kinases C (PKC) and PKA have no effect. In contrast to its effects on IL-8 expression, pyocyanin inhibits cytokine-dependent expression of the monocyte/macrophage/T-cell chemokine RANTES. Increased release of IL-8, a potent neutrophil chemoattractant, in response to pyocyanin could contribute to the marked infiltration of neutrophils and subsequent neutrophil-mediated tissue damage that are observed in Pseudomonas-associated lung disease.


Subject(s)
Interleukin-8/biosynthesis , Lung/immunology , Pseudomonas , Pyocyanine/pharmacology , Acetylcysteine/pharmacology , Antioxidants/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cells, Cultured , Chemokine CCL5/biosynthesis , Drug Synergism , Epithelial Cells/cytology , Epithelial Cells/immunology , Humans , Interleukin-8/genetics , Lung/cytology , Oxidants/metabolism , Protein Kinase C/antagonists & inhibitors , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , RNA, Messenger/analysis , Signal Transduction , Tumor Necrosis Factor-alpha/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...